Detection of methicillin-resistant Staphylococcus aureus using double duplex real-time PCR and dye Syto 9
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu hodnotící studie, časopisecké články, práce podpořená grantem
- MeSH
- bakteriální chromozomy genetika MeSH
- lidé MeSH
- methicilin rezistentní Staphylococcus aureus účinky léků genetika izolace a purifikace MeSH
- methicilin farmakologie MeSH
- organické látky metabolismus MeSH
- polymerázová řetězová reakce metody MeSH
- prediktivní hodnota testů MeSH
- rezistence na methicilin genetika MeSH
- senzitivita a specificita MeSH
- stafylokokové infekce diagnóza mikrobiologie MeSH
- Staphylococcus aureus klasifikace účinky léků genetika izolace a purifikace MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- hodnotící studie MeSH
- práce podpořená grantem MeSH
- Názvy látek
- methicilin MeSH
- organické látky MeSH
- SYTO 9 MeSH Prohlížeč
A screening method for methicillin-resistant Staphylococcus aureus (MRSA) using real-time polymerase chain reaction (PCR) and dye Syto 9 was developed and evaluated. The assay was based on the two duplex reactions run simultaneously. The detection reaction amplified staphylococcal cassette chromosome mec (SCCmec) right extremity sequences and S. aureus-specific 442-bp DNA (Sa442). The control reaction amplified S. aureus-specific nuclease gene nuc and a marker of methicillin resistance, mecA. The method was evaluated by analyzing 214 clinical S. aureus isolates yielding 98.7 % sensitivity, 100 % specificity, 100 % positive predictive value and 96.6 % negative predictive value for detection of MRSA. The detection limit was determined to be 15-80 genome copies per real-time PCR. It was able to discriminate between MRSA, methicillin resistant coagulase negative staphylococci and methicillin susceptible S. aureus (MSSA) isolates containing only small fragments of the right extremity of the SCCmec (MSSA revertants).
Zobrazit více v PubMed
Drug Resist Updat. 2003 Feb;6(1):41-52 PubMed
J Clin Microbiol. 2004 Dec;42(12):5578-81 PubMed
Int J Antimicrob Agents. 2009 Jul;34 Suppl 1:S15-9 PubMed
J Clin Microbiol. 2003 Jul;41(7):2894-9 PubMed
Microb Drug Resist. 2000 Summer;6(2):133-41 PubMed
Nat Rev Microbiol. 2009 Sep;7(9):629-41 PubMed
Eur J Clin Microbiol Infect Dis. 2007 Jul;26(7):459-66 PubMed
Biochem Biophys Res Commun. 2008 Dec 19;377(3):752-6 PubMed
Eur J Clin Microbiol Infect Dis. 2007 Oct;26(10):751-4 PubMed
J Clin Microbiol. 2009 Jun;47(6):1689-94 PubMed
Am J Clin Pathol. 2005 Sep;124(3):404-7 PubMed
Antimicrob Agents Chemother. 1981 May;19(5):726-35 PubMed
Antimicrob Agents Chemother. 2002 Apr;46(4):1147-52 PubMed
J Clin Microbiol. 2004 May;42(5):1875-84 PubMed
Antimicrob Agents Chemother. 2005 May;49(5):2070-83 PubMed
J Clin Microbiol. 2009 May;47(5):1524-7 PubMed
J Clin Microbiol. 2007 Sep;45(9):2993-8 PubMed
Antimicrob Agents Chemother. 1999 Jun;43(6):1449-58 PubMed
J Clin Microbiol. 2006 Jun;44(6):2317 PubMed
Clin Microbiol Infect. 2006 Dec;12(12):1163-7 PubMed
J Clin Microbiol. 2006 Apr;44(4):1219-23 PubMed
Eur J Clin Microbiol Infect Dis. 2006 Oct;25(10):657-63 PubMed
Antimicrob Agents Chemother. 2006 Oct;50(10):3457-9 PubMed
J Clin Microbiol. 2006 Jan;44(1):229-31 PubMed
J Microbiol Methods. 2007 Feb;68(2):296-302 PubMed
Emerg Infect Dis. 2001 Mar-Apr;7(2):170-3 PubMed
Antimicrob Agents Chemother. 2009 Feb;53(2):531-40 PubMed
Nucleic Acids Res. 2007;35(19):e127 PubMed
